Citadel Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Sell
6,100
-100
-2% -$3.71K ﹤0.01% 11385
2025
Q4
$216K Buy
+6,200
New +$229K ﹤0.01% 10886
2025
Q2
Sell
-1,400
Closed -$37.8K 13293
2025
Q1
$37.8K Buy
1,400
+700
+100% +$20.5K ﹤0.01% 12597
2024
Q4
$20K Sell
700
-1,700
-71% -$49.5K ﹤0.01% 13182
2024
Q3
$64.6K Buy
+2,400
New +$63.2K ﹤0.01% 11637
2024
Q2
Sell
-500
Closed -$13.8K 14599
2024
Q1
$13.8K Buy
500
+100
+25% +$2.61K ﹤0.01% 13275
2023
Q4
$9.75K Sell
400
-1,600
-80% -$36.4K ﹤0.01% 13140
2023
Q3
$44.8K Buy
+2,000
New +$48.3K ﹤0.01% 11878
2023
Q2
Sell
-2,900
Closed -$68.6K 14595
2023
Q1
$68.6K Buy
2,900
+2,600
+867% +$59.7K ﹤0.01% 11767
2022
Q4
$6.55K Buy
+300
New +$7.4K ﹤0.01% 13907
2022
Q2
Sell
-8,500
Closed -$332K 13214
2022
Q1
$332K Buy
8,500
+1,100
+15% +$42.7K ﹤0.01% 10353
2021
Q4
$339K Buy
+7,400
New +$353K ﹤0.01% 10650
2021
Q2
Sell
-26,500
Closed -$1.16M 13891
2021
Q1
$1.16M Buy
+26,500
New +$1.2M ﹤0.01% 7731

Other funds holding FFTY

Citadel Advisors's FFTY Position: Q1 2026 in Review

Citadel Advisors increased its CapForce IBD 50 ETF (FFTY) stake by 556% in Q1 2026, buying an estimated $1.28M and bringing the position to 40,706 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #6950.

Citadel Advisors first reported a position in FFTY in Q3 2015 and has held it in 33 quarters since. The position peaked at $3.97M in Q3 2021. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • Citadel Advisors held 40,706 shares of CapForce IBD 50 ETF worth $1.36M as of Q1 2026.
  • Citadel Advisors bought 34,498 CapForce IBD 50 ETF shares in Q1 2026, an estimated $1.28M.
  • CapForce IBD 50 ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6950 holding.
  • Citadel Advisors first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 33 quarters since.
  • Citadel Advisors's CapForce IBD 50 ETF position peaked at $3.97M in Q3 2021.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.